Association between the use of selective serotonin reuptake inhibitors and multiple sclerosis disability progression

Tingting Zhang, Elaine Kingwell, Hilda J. I. De Jong, Feng Zhu, Yinshan Zhao, Robert Carruthers, John Petkau, Paul Gustafson, Joel Oger, Helen Tremlett*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1150-1159
JournalPharmacoepidemiology and Drug Safety
Issue number10
Publication statusPublished - Oct 2016


  • multiple sclerosis
  • disability progression
  • SSRIs
  • effectiveness
  • population-based data
  • pharmacoepidemiology

Cite this